Interestingly, all CD45−/CD326+/CD338+ cells recipient mice (5/5) exhibited tumor formation in the lung compared to mice that received the CD45−/CD326−/CD338− cells (0/5) (Fig. 2h and Supplementary Figure S2D). This evidence concerns the gene PTPRC and neoplasm.